Amgen to Develop New Chemicals for Kodak
- Share via
Eastman Kodak has agreed to provide approximately $10 million in cash over the next four years for Amgen, a Newbury Park biotechnology company, to develop new ways of making specialty chemicals with genetic engineering.
Under the agreement, Kodak would do the manufacturing, and the two companies would share any profit from the sale of products made with Amgen-developed technology. The profit-sharing formula was not disclosed.
Amgen has a similar deal to help Texaco make specialty chemicals.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
